BioMarin
BioMarin is a biotechnology company that develops and commercializes therapeutics for the treatment of genetic diseases.
Business Model:
Revenue: $2B
Employees: 1,001-5,000
Industries / Tags:
Detailed BioMarin Information
Geographic Data
Address: 770 Lindaro Street
City: San Rafael
State: CA
Zip: 94901
Country: US
Financial Info
Stage:
post ipo debt
Raised Last:
$586M
Raised Total:$586M
Social
Metrics
1,460,395Website Global Rank
18,081Website Monthly Traffic
Twitter Followers
Description
BioMarin is a biotechnology company that develops and commercializes therapeutics for the treatment of genetic diseases.
Contact Phone:
+14155066700
Contact Email:
BioMarin went public on 7/23/1999 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
7/23/1999
Ticker Symbol:
BMRN
IPO Price:
$13/share
Amount Raised:
$59M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 2/1997 | Unattributed | $1.5M | 6/2018 | Debt | $20M |
Pfizer Inc |
5/2020 | Post-IPO Debt | - | 5/2020 | Post-IPO Debt | $585.8M | 5/2020 | Private Placement | $550M | 7/1999 | IPO | $58.5M | 5/2020 | Post-IPO Debt | - |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 11/2014 | Prosensa | |
| 1/2013 | Zacharon Pharmaceuticals | |
| 8/2010 | Zystor | |
| 2/2010 | LEAD Therapeutics | |
| 10/2009 | Huxley Pharmaceuticals | |
| 2/2002 | Glyko Biomedical |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
